US Pharma MarketingEli Lilly on Site Enablement: Co-Designing Solutions with Sites
Eli Lilly on Site Enablement: Co-Designing Solutions with Sites is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
A case study highlighting how Eli Lilly partnered with clinical sites to co-design practical, site-centric solutions that enhanced trial execution and operational efficiency.
Source: FierceBiotech